chemotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
chemotherapy
Apr 28, 2024, 11:04 |
Blog
Ana I. Velázquez Mañana: ASCO24 abstract titles are out! Exciting Plenary Session, specially for LCSM community
Ana I. Velázquez Mañana shared on X/Twitter: “ASCO24 abstract titles are out! Exciting Plenary Session, specially…
Apr 27, 2024, 11:36 |
Drugs
ASCO's Open Letter to Congress and the Administration To End Cancer Drug Shortages
The American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "Did you know…
Apr 27, 2024, 11:29 |
Insight
APCCC24 Highlights: Chemotherapy and PSMA radioligand therapy by Yüksel Ürün
Yüksel Ürün, Professor of Medicine at the Ankara University School of Medicine, shared on X/Twitter:…
Apr 26, 2024, 13:29 |
Blog
Mark Lewis: How one of my patients described chemo cycles and oh my
Quoting Mark Lewis on X/Twitter: "This is how one of my patients described chemo cycles…
Apr 26, 2024, 10:07 |
Drugs
Rami Manochakian: U.S. FDA approves adjuvant Alectinib in patients with stage IB-IIIA ALK+Non-Small Cell Lung Cancer
Rami Manochakian, Associate Professor and Thoracic Oncologist at Mayo Clinic, shared on X/Twitter: ''HOT OFF…
Apr 26, 2024, 10:00 |
Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
Apr 24, 2024, 22:02 |
Blog
Michael Shusterman: Just a reminder about why we should NOT use bolus 5-FU in combination with the infusion
Michael Shusterman, Medical oncologist and Clinical Assistant Professor of Medicine in the Permutter Cancer Center…
Apr 23, 2024, 23:25 |
Drugs
Jarushka Naidoo: Pooled 5-year outcomes of Pembrolizumab and Chemotherapy for PDL less than 1% metastatic NSCLC in the Journal of Thoracic Oncology
Jarushka Naidoo shared on X: “Pooled 5-yr outcomes of Pembrolizumab and Chemotherapy for PDL1<1% metastatic…
Apr 22, 2024, 20:04 |
Insight
Maryam Diba: Immunogenic cell death-based cancer vaccines promising prospect in cancer
Maryam Diba, Immunologist at Tehran University of Medical Sciences, shared on LinkedIn: "Immunogenic cell death-based cancer…
Apr 22, 2024, 18:48 |
Insight
Piotr Wysocki: Single-agent immunotherapy is a wise choice as first-line treatment in elderly, advanced NSCLC patients, irrespectively of PD-L1 expression
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
2
3
4
5
6
All:
98
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube